Upcoming Medical Conferences in La JollaSearch Criteria : United States of America La Jolla
Oct 29 - Nov 01, 2019 | CME 23.00 | La Jolla, California
30th Annual Cardiovascular Interventions is organized by Promedica International CME and will be held from Oct 29 - Nov 01, 2019 at Hilton La Jolla Torrey Pines, La Jolla, California, United States of America. Target Audience: This course is designed for interventional cardiologists, cardiac surgeons, vascular surgeons, internists, NPs, PAs, nurses, cath lab technicians, perfusionists, registered cardiovascular invasive specialists, radiologic technologists, and those with a special interest in interventional cardiology. No experience in interventional cardiology is required, however a basic understanding of the field is recommended. Program Description: Join us to celebrate 30 remarkable years of interesting and complicated state-of-the-art live case transmissions and expert faculty contributions as we continue to explore the exciting future of interventional cardiology! The practice of medicine changes rapidly and the discipline of interventional cardiology changes dramatically each year. Changes in interventional cardiology directly impact patient care and require constant updates to physician knowledge and practices. The primary purpose of the “30th Annual Cardiovascular Interventions” symposium is to provide the practicing physician and cardiovascular care team with a concentrated exposure to new developments in interventional cardiology that will positively influence patient outcomes. By attending this program, participants will learn the latest advances and debates in interventional cardiology. They will return to their practice environment armed with the latest evidence-based, practical information to improve patient care and outcomes. Educational Objectives After attending this activity, participants should be able to: • Apply new technical approaches to specific lesion subsets such as bifurcation lesions, left main lesions, chronic total occlusions and saphenous vein graft disease • Integrate the latest guidelines and practice improvements into the management of myocardial function • Discuss new techniques under development for transcatheter cardiac valve repair and replacement • Reduce common catheterization laboratory patient complications using new techniques and technologies • Critique the latest evidence supporting new cardiac imaging modalities such as IVUS, OCT and FFR guided stent deployment • Prescribe the appropriate antithrombotic therapies based on the latest data and guidelines CME Accreditation and Designation: Promedica International is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Promedica International designates this live activity for a maximum of 23 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing Contact Hours Provider approved by the California Board of Registered Nursing, Provider #8495 for 23 Contact Hours. Perfusion CEUs The American Board of Cardiovascular Perfusion (ABCP) has approved a total of 27.6 Category 1 CEUs for perfusionists for Wednesday, October 30 (4.8), Thursday, October 31 (11.4), and Friday, November 1 (11.4). ABIM MOC Accreditation Successful completion of this CME activity, which includes participation in the evaluation component enables the participant to earn up to 23 Medical Knowledge MOC points and Patient Safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. Radiation Safety This conference fulfills the Title 17 California Code requirement for 4 CE credits in radiation safety for the clinical uses of fluoroscopy.
Nov 01, 2019 | La Jolla, California
Regulation of Neuronal Functions in Health and Disease - 40th Annual Symposium is organized by Sanford Burnham Prebys (SBP) Medical Discovery Institute and will be held on Nov 01, 2019 at Estancia La Jolla Hotel & Spa, La Jolla, California, United States of America. Additional details will be posted as soon as they are available.
Dec 05 - 07, 2019 | La Jolla, California
28th Annual Course in Advanced Gynecologic Surgery is organized by Society of Gynecologic Surgeons (SGS) and will be held from Dec 05 - 07, 2019 at La Jolla, California, United States of America. Additional details will be posted as soon as they are available.
Dec 07 - 08, 2019 | La Jolla, California
AONA: CMF Management of Facial Trauma is organized by AO North America (AONA) and will be held from Dec 07 - 08, 2019 at San Diego Marriott La Jolla, La Jolla, California, United States of America. Target Audience: This course is primarily designed for surgeons in training in the fields of Oral and Maxillofacial Surgery, Otolaryngology, Plastics and Reconstruction, Ophthalmology and Oculoplastics. Some practicing surgeons may also find this course beneficial. Description: The Management of Facial Trauma course for residents and fellows is designed to equip young surgeons with evidence-based clinical approaches to treat and manage CMF fractures and congenital defects through the correction of these injuries or defects and establishment of aesthetic outcomes. Central to this entire course are the four guiding AO Principles of Fracture Fixation: • Anatomic reduction of the fracture fragments, particularly joint fractures • Stable fixation to ensure proper healing of the fracture allowing surrounding tissue to move and strengthen • Atraumatic surgical technique to preserve blood supply to the bone fragments and soft tissue • Early, pain free mobilization returning the patient to function as soon as possible AOCMF faculty at these courses are recognized national experts who are academic-based clinicians from leading universities and hospitals in North America representing all the disciplines involved in craniomaxillofacial surgery. The course is constructed in a modular format that focuses on the craniomaxillofacial patient through: • Brief didactic lectures • Multiple interactive, clinical case-based small group discussion breakouts • Several hands-on practical exercises using Sawbones models Other curricular highlights include sessions on anatomy, biomechanics, multiple surgical approaches and principles of internal fixation of the mandible and midface. Learning Objectives: Upon completion, participants should be able to: • Diagnose facial injury through history, physical examination, and diagnostic investigations • Formulate a treatment plan (operative and non-operative) • Perform the specific treatment for facial trauma • Modify the treatment plan when necessary • Manage patient follow-up and rehabilitation • Identify and manage complications Additional details will be posted as soon as they are available.
Dec 07, 2019 | CME 4.25 | USD $85 | La Jolla, California
2019 Update in Rheumatology: Highlights from the ACR and EULAR Meetings is organized by UC San Diego School of Medicine Continuing Medical Education and will be held on Dec 07, 2019 at UC San Diego Altman Clinical and Translational Research Institute, San Diego, California, United States of America. Target Audience: Physicians and allied health care professionals specializing in rheumatology. Accreditation: AMA: The University of California, San Diego School of Medicine designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. AAPA: Physician assistants may receive a maximum of 4.25 hours of Category 1 credit for completing this program. Nurses: For the purpose of relicensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credits™ (report up to 4.25 hours of credit and list “CME Category 1” as the provider number). Description: The Rheumatology landscape is ever-evolving. In recent decades there have been significant and rapid advances in the understanding of the immunopathogenesis of many rheumatic diseases. This has led to improvements in the diagnosis and stratification of patients, as well as in more efficient treatments and overall management of many rheumatic diseases. In order to transform this knowledge into better outcomes for patients, rheumatologists require ongoing education and insight regarding optimal patient assessment as well as the benefits and risks of large and expanding number of potential therapeutic agents and treatment strategies. The goal of this activity is to provide rheumatologists with current, evidence-based data that can be translated into clinical practice in order to maximize therapeutic goals and optimize healthcare outcomes for patients with various rheumatic diseases. This ½ day, comprehensive CME activity will utilize evidence-based data around the management of rheumatic diseases. Didactic teaching, along with interactive discussions and case-based discussion will enhance the relevancy providing rheumatologists with the ability to apply the latest data into clinical practice. Objectives: At the conclusion of this activity participants should be able to: • Examine the immunopathogenesis underlying various rheumatologic, systemic inﬂammatory, autoimmune disorders • Recognize the importance of early and aggressive management of rheumatologic diseases in order to optimize longer term outcomes • Discuss the mechanisms of action of various drugs and immunomodulatory agents commonly used in rheumatology and be aware of their place in current guidelines • Explain the possible adverse events, common and uncommon, that may be associated with the use of various immunomodulatory agents; describe how to stratify and monitor patients to optimize safety • Discuss the importance of shared decision making and effective clinician-patient communications • Recognize major issues and advances related to the management of patients with rheumatoid arthritis, systemic lupus erythematosus, vasculitis, psoriatic arthritis, axial spondyloarthritis, gout, pseudogout, osteoarthritis, osteoporosis, and other common rheumatologic disorders
Jan 18, 2020 | CME 4.50 | USD $100 | La Jolla, California
Fourth Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension is organized by Scripps Health and will be held on Jan 18, 2020 at Schaetzel Center, La Jolla, California, United States of America. This CME conference is designed to educate clinicians on state-of-the-art care for pulmonary hypertension. Accreditation: Physicians: Scripps Health designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. ABIM MOC Points: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Physician Assistants: PAs may claim a maximum of 4.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Course Overview: Pulmonary hypertension (PH) is a common and widely misunderstood syndrome that results from a surprisingly large number of disease processes. It can occur at any age and the risk of developing PH increases with age and other medical conditions. Great strides have been made in the past 15 years in diagnosing and treating pulmonary arterial hypertension (PAH) so that the natural history of PAH is rapidly changing. On the other hand, the more common clinical variant, pulmonary venous hypertension (PVH) has been largely unaffected by medical therapy. In addition, there is often a divide between those whose treat PAH and those clinicians whose patients have PVH and are frustrated by the lack of effective therapy. This conference will be unique in that it will cover all forms of pulmonary hypertension. Expert faculty will discuss the epidemiology of PH, how PH is diagnosed, and the poor outcomes associated with PH when left untreated. Clinicians will leave with a better understanding of the difference between PAH and PVH and why the difference matters. Therapies for PAH and PVH will also be discussed with reference to current clinical guidelines. Participants will return to their practice equipped with the latest evidence base and practical information to improve patient outcomes. Educational Objectives: After attending this live activity, participants should be able to: • Describe the epidemiology and pathophysiology of pulmonary hypertension. • Determine who is at risk for pulmonary hypertension and effectively diagnose patients. • Recognize the difference between PAH and PVH and how this translates into therapy. • Outline the current approach to pulmonary hypertension treatment in the presence of related or underlying diseases. • Evaluate current pharmacologic and medical management strategies for patients with pulmonary hypertension. • Incorporate novel therapies into patient care for improved outcomes. • Identify when to refer patients for specialty treatment.
Jan 25 - 26, 2020 | La Jolla, California
14th Annual UCSD Regional Anesthesia Course is organized by UC San Diego School of Medicine Continuing Medical Education and will be held from Jan 25 - 26, 2020 at UC San Diego Center for the Future of Surgery, La Jolla, California, United States of America. This course will offer: • Basic Ultrasound Workshop with didactic lectures, hands on Ultrasound imaging workshop in human models, anatomical dissections and simulation • Advanced Ultrasound Workshop to perform blocks in human cadavers under faculty guidance and Infraclavicular block phantom for practice • Ultrasound Guided Vascular Access Workshop for arterial, central and peripheral venous lines Additional details will be posted as soon as information is available.
Jan 30 - Feb 01, 2020 | La Jolla, California
12th Annual T-cell Lymphoma Forum is organized by Jonathan Wood & Associates (JWA) and will be held from Jan 30 - Feb 01, 2020 at Hilton La Jolla Torrey Pines, La Jolla, California, United States of America. Target Audience: This meeting is intended for hematologists, oncologists, and other clinicians and scientists with an interest in T-cell lymphoma. Description: The T-cell Lymphoma Forum provides just the platform for attendees and world leaders in TCL to gather and exchange ideas and information to improve outcomes for this patient population. Plan to join our distinguished international faculty for this informative program. Additional details will be posted as soon as they are available.
Feb 06 - 07, 2020 | La Jolla, California
3rd Long-Acting Injectables & Implantables Conference is organized by Controlled Release Society (CRS) and will be held from Feb 06 - 07, 2020 at The Alexandria, La Jolla, California, United States of America. Additional details will be posted as soon as they are available.
Mar 18, 2020 | La Jolla, California
2020 Cancer Immunology and the Tumor Microenvironment Symposium is organized by SBP's NCI-Designated Cancer Center and will be held on Mar 18, 2020 at Sanford Consortium for Regenerative Medicine, La Jolla, California, United States of America. Course Description: Research in this program aims to understand the molecular basis of how cells interact with each other and with the molecules in their environment, and how these processes promote tumor growth and metastasis. We also explore how the immune system is altered to promote tumor growth, and how tumor cells stimulate the production of new blood vessels (angiogenesis) to gain access to nutrients and metastasize. This is the starting point for the identification of strategies to modify the tumor microenvironment to inhibit tumor growth and metastasis. Additional details will be posted as soon as the information is available.